Rg1 protects iron-induced neurotoxicity through antioxidant and iron regulatory proteins in 6-OHDA-treated MES23.5 cells

Journal of Cellular Biochemistry

Volumn 111, Issue 6, 2010, Pages 1537-1545

  Xu, Huamin ^a   Jiang, Hong ^a   Wang, Jun ^a   Xie, Junxia ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

6 hydroxydopamine (6 OHDA); antioxidant; ferrous iron; iron regulatory protein (IRP); Rg1

Indexed keywords

ANTIOXIDANT; FERROUS ION; GINSENOSIDE RG 1; IRON; IRON REGULATORY FACTOR; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; OXIDOPAMINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME INHIBITION; IRON OVERLOAD; IRON RESPONSIVE ELEMENT; MEMBRANE POTENTIAL; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL LINE, TUMOR; FLOW CYTOMETRY; GINSENOSIDES; IRON; IRON-REGULATORY PROTEINS; MICE; NEURONS; OXIDOPAMINE; POLYMERASE CHAIN REACTION; RATS; REACTIVE OXYGEN SPECIES;

PANAX GINSENG;

EID: 78649782421     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22885     Document Type: Article

References (50)

1. Alvira D, Yeste-Velasco M, Folch J, Verdaguer E, Canudas AM, Pallas M, Camins A,. 2007. Comparative analysis of the effects of resveratrol in two apoptotic models: Inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience 147: 746-756.
2. Attele AS, Wu JA, Yuan CS,. 1999. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693.
3. Berg D, Hochstrasser H, Schweitzer KJ, Riess O,. 2006. Disturbance of iron metabolism in Parkinson's disease-Ultrasonography as a biomarker. Neurotox Res 9: 1-13.
4. Bostanci MO, Bagirici F,. 2008. Nitric oxide synthesis inhibition attenuates iron-induced neurotoxicity: A stereological study. Neurotoxicology 29: 130-135.
5. Chen XC, Zhu YG, Zhu LA, Huang C, Chen Y, Chen LM, Fang F, Zhou YC, Zhao CH,. 2003. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur J Pharmacol 473: 1-7.
6. Chwa M, Atilano SR, Reddy V, Jordan N, Kim DW, Kenney MC,. 2006. Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts. Invest Ophthalmol Vis Sci 47: 1902-1910.
7. Crawford GD, Jr., Le WD, Smith RG, Xie WJ, Stefani E, Appel SH,. 1992. A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci 12: 3392-3398.
8. Eisenstein RS,. 2000. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 20: 627-662.
9. Foley P, Riederer P,. 2000. Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease. J Neurol 247 (Suppl 2): II82-II94.
10. Gao QG, Chen WF, Xie JX, Wong MS,. 2009. Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways. J Neurochem 109: 1338-1347.
11. Ge KL, Chen WF, Xie JX, Wong MS,. 2010. Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways. J Ethnopharmacol 127: 118-123.
12. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA,. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482-488.
13. Hall S, Rutledge JN, Schallert T,. 1992. MRI, brain iron and experimental Parkinson's disease. J Neurol Sci 113: 198-208.
14. Hanrott K, Gudmunsen L, O'Neill MJ, Wonnacott S,. 2006. 6-Hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem 281: 5373-5382.
15. Hanson ES, Leibold EA,. 1999. Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species. Gene Expr 7: 367-376.
16. Hentze MW, Kuhn LC,. 1996. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93: 8175-8182.
17. Huang E, Ong WY, Go ML, Connor JR,. 2006. Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury. Exp Brain Res 170: 376-386.
18. Hubert N, Hentze MW,. 2002. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function. Proc Natl Acad Sci USA 99: 12345-12350.
19. Jiang H, Luan Z, Wang J, Xie J,. 2006. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 49: 605-609.
20. Jiang H, Song N, Wang J, Ren LY, Xie JX,. 2007. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem Int 51: 32-36.
21. Jiang H, Song N, Xu HM, Zhang SZ, Wang J, Xie JX,. 2010. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent. Cell Res 20: 345-356.
22. Lee PL, Gelbart T, West C, Halloran C, Beutler E,. 1998. The human Nramp2 gene: Characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis 24: 199-215.
23. Lee JH, Kim SR, Bae CS, Kim D, Hong H, Nah S,. 2002. Protective effect of ginsenosides, active ingredients of Panax ginseng, on kainic acid-induced neurotoxicity in rat hippocampus. Neurosci Lett 325: 129-133.
24. Leung KW, Yung KK, Mak NK, Chan YS, Fan TP, Wong RN,. 2007. Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity. Neuropharmacology 52: 827-835.
25. Liu CX, Xiao PG,. 1992. Recent advances on ginseng research in China. J Ethnopharmacol 36: 27-38.
26. Mackenzie B, Takanaga H, Hubert N, Rolfs A, Hediger MA,. 2007. Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem J 403: 59-69.
27. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ,. 2000. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309.
28. Mladenka P, Simunek T, Hubl M, Hrdina R,. 2006. The role of reactive oxygen and nitrogen species in cellular iron metabolism. Free Radic Res 40: 263-272.
29. 2) control mammalian iron metabolism by different pathways. Mol Cell Biol 16: 3781-3788.
30. Picard V, Govoni G, Jabado N, Gros P,. 2000. Nramp 2 (DCT1/DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool. J Biol Chem 275: 35738-35745.
31. Ponting CP,. 2001. Domain homologues of dopamine beta-hydroxylase and ferric reductase: Roles for iron metabolism in neurodegenerative disorders? Hum Mol Genet 10: 1853-1858.
32. Qian Z, Wang Q, Pu Y,. 1997. Brain iron and neurological disorders. Chin Med J (Engl) 110: 455-458.
33. Radad K, Gille G, Moldzio R, Saito H, Ishige K, Rausch WD,. 2004a. Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells. J Neural Transm 111: 37-45.
34. Radad K, Gille G, Moldzio R, Saito H, Rausch WD,. 2004b. Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res 1021: 41-53.
35. Sachs C, Jonsson G,. 1975. Mechanisms of action of 6-hydroxydopamine. Biochem Pharmacol 24: 1-8.
36. Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, Duyckaerts C, Sazdovitch V, Zhao L, Garrick LM, Nunez MT, Garrick MD, Raisman-Vozari R, Hirsch EC,. 2008. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci USA 105: 18578-18583.
37. Sanelli T, Ge W, Leystra-Lantz C, Strong MJ,. 2007. Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant. J Neurol Sci 256: 39-51.
38. Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB,. 1988. Increased iron (III) and total iron content in post mortem substantia nigra of Parkinsonian brain. J Neural Transm 74: 199-205.
39. Song N, Jiang H, Wang J, Xie JX,. 2007. Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. J Neurosci Res 85: 3118-3126.
40. Song N, Wang J, Jiang H, Xie J,. 2010. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease. Free Radic Biol Med 48: 332-341.
41. Tenopoulou M, Doulias PT, Barbouti A, Brunk U, Galaris D,. 2005. Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem J 387: 703-710.
42. Wang J, Jiang H, Xie JX,. 2007. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats. Eur J Neurosci 25: 2766-2772.
43. Wang J, Xu HM, Yang HD, Du XX, Jiang H, Xie JX,. 2009. Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochem Int 54: 43-48.
44. Wetli HA, Buckett PD, Wessling-Resnick M,. 2006. Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake. Chem Biol 13: 965-972.
45. Xu L, Liu LX, Chen WF,. 2008. Effect and mechanism on dopamine contents of striatum in rat model of Parkinson's disease ginsenoside Rg1. Zhongguo Zhong Yao Za Zhi 33: 1856-1859.
46. Xu L, Chen WF, Wong MS,. 2009. Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway. Br J Pharmacol 158: 738-748.
47. Xu H, Jiang H, Wang J, Xie J,. 2010. Rg1 protects the MPP(+)-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake. Neuropharmacology 58: 488-494.
48. Youdim MB, Stephenson G, Ben Shachar D,. 2004. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: A lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann NY Acad Sci 1012: 306-325.
49. Zhang S, Wang J, Song N, Xie J, Jiang H,. 2009. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Neurobiol Aging 30: 1466-1476.
50. Zhu HJ, Liu GQ,. 2004. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism. Life Sci 75: 1313-1322.